The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.

about

Lipid-lowering therapies and achievement of LDL-cholesterol targets Hypertriglyceridemia - Common Causes, Prevention and treatment Strategies

P2860

Q36286258-9078C883-4819-4A70-955A-7AD627A05E50 Q49798045-6EA5A8F6-C56D-40DC-AF97-203B15191417

P2860

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.

Item

http://www.wikidata.org/entity/Q35843906

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The clinical benefit of implem ...... ention in real world settings.

@ast

The clinical benefit of implem ...... ention in real world settings.

@en

type

Item

label

The clinical benefit of implem ...... ention in real world settings.

@ast

The clinical benefit of implem ...... ention in real world settings.

@en

prefLabel

The clinical benefit of implem ...... ention in real world settings.

@ast

The clinical benefit of implem ...... ention in real world settings.

@en

P1476

The clinical benefit of implem ...... ention in real world settings.

@en

P2093

Asterios Karagiannis

http://www.w3.org/2001/XMLSchema#string

Niki Katsiki

http://www.w3.org/2001/XMLSchema#string

Thomas D Gossios

http://www.w3.org/2001/XMLSchema#string

Vasilios G Athyros

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

The Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease--results after one year

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

Medication performance measures and mortality following acute coronary syndromes

A quality guarantee in acute coronary syndromes: the American College of Cardiology's Guidelines Applied in Practice program taken real-time

Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study

Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.

Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).

Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

P304

6-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2012.27272

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dimitri P Mikhailidis

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223137375

http://www.w3.org/2001/XMLSchema#string

P698

22457666

http://www.w3.org/2001/XMLSchema#string

P932

3309428

http://www.w3.org/2001/XMLSchema#string

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.

about

P2860

P2860

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932